ARS Pharmaceuticals, Inc. (SPRY) - Total Stockholders' Equity

Public company logo of ARS Pharmaceuticals, Inc. (SPRY)

This daily price chart for SPRY shows indicators at 0.01, while ARS Pharmaceuticals has developed a unique nasal adrenaline for treating allergic shocks. The company is investing in needle-free delivery methods and scientific research. Its competitive advantage is secured by patents for a comfortable spray that is displacing traditional injectable devices.

SPRY ARS Corp Book Capitalization (04/28/2023 - 10/27/2026)

Metric breakdowns and analytics for ARS Pharmaceuticals, Inc. (SPRY)

- price and consensus price forecast:
Price Performance Chart ARS Corp|SPRY - Consensus Target
- market capitalization data:
Market Value ARS Pharmaceuticals Inc|SPRY - Total Company Value
- book capitalization data:
Share Book Value ARS Pharmaceuticals|SPRY - Book Capitalization|Market Value to Book Value ars-pharma.com|SPRY - Company Total Assets
- debt and liquidity data:
Total Debt to Capital ARS Pharmaceuticals|SPRY - Long-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital ARS Pharmaceuticals Inc|SPRY - Company Debts|Debt to Book Value ARS Pharmaceuticals Inc
Fundamental valuation:SPRY - ARS Corp
Flagship merchandise of ARS Pharmaceuticals Inc

Book value reflects the net value of the company's assets minus all liabilities. This metric demonstrates the speed at which operating profit is converted into real capital. By analyzing the firm's book value history, an investor can quickly detect hidden resource erosion. For ARS Pharmaceuticals (SPRY), this indicator confirms financial stability during the implementation of its innovative nasal spray. Capital growth here enables the scaling of a product that replaces traditional injections.

Competitor analysis for ARS Pharmaceuticals

Haleon Corp (HLN) - Accounting Value of Company|Company Net Assets KVUE|VRNA (veronapharma.com) - Total Stockholders' Equity|Company Book Value Jyong Biotech MENS|Net Asset Value Ligand Pharmaceuticals Incorporated|Amneal Pharmaceuticals Inc (AMRX) - Book Capitalization|Accounting Value of Company Perrigo Corp (PRGO)|Book Capitalization ALVO (Alvotech)|liquidia.com - Book Capitalization|Company Book Value Galapagos (GLPG)|ANIP: Accounting Value of Company|MNKD (MannKind Corp.) - Company Book Value|Amphastar Corp (AMPH) - Company Net Assets|PCRX (Pacira BioSciences) - Book Capitalization|Book Capitalization theravance.com (TBPH)|Aquestive Therapeutics, Inc. (AQST) - Company Net Assets|Accounting Value of Company SCPH (scpharmaceuticals.com)|TECX: Company Book Value|TNXP - Total Stockholders' Equity|Company Net Assets SXT China SXTC|EPRX - Total Net Assets|Book Capitalization BioHarvest Sciences Inc. BHST|Invizyne Technologies (EXOZ) - Accounting Value of Company|Book Capitalization ORMP (Oramed)|Total Stockholders' Equity ENTX|MindWalk Holdings (HYFT) - Company Book Value|Accounting Value of Company abvcpharma.com (ABVC)|Book Capitalization CPIX (Cumberland Pharmaceuticals Inc.)|Quantum BioPharma Ltd. - Book Capitalization|Company Book Value FibroGen Corp (FGEN)|TELO: Accounting Value of Company|ranitherapeutics.com - Company Book Value|Book Valuation of Business Synergy CHC|RLYB - Company Net Assets|Accounting Value of Company LEXX|PULM - Company Book Value|Net Asset Value ftzy.com.cn (PTHL)|Book Capitalization Aptorum Group|Accounting Value of Company lyratherapeutics.com LYRA|Impact BioMedical Inc - Book Capitalization|TNFA: Book Capitalization|Company Book Value cbdmd.com YCBD|PRFX (PainReform Corp) - Accounting Value of Company|Company Book Value CYTO|Company Net Assets lipella.com|Book Capitalization OPTN|Book Capitalization Pieris Pharmaceuticals Inc (PIRS)|Procaps Group SA - Book Capitalization|Company Net Assets Petros Pharma PTPI|QLI (Qilian International) - Book Capitalization|acelyrin.com (SLRN) - Total Stockholders' Equity|TFFP: Company Net Assets